Beste apotheek van Nederland

Carosa E, Martini P, Brandetti F et al. Type V
phosphodiesterase inhibitor treatments for erectile dysfunction
increase testosterone levels. Clin Endocrinol (Oxf)
2004;61(3):382-386.
Carson C C, Burnett A L, Levine L A et al. The efficacy of
sildenafil citrate (Viagra) in clinical populations: an update.
Urology 2002;60(2 Suppl 2):12-27.
Carson C C, Rajfer J, Eardley I et al. The efficacy and safety of
tadalafil: an update. BJU Int 2004;93(9):1276-1281.
Caruso S, Intelisano G, Farina M et al. Efficacy and safety of
daily intake of apomorphine SL in men affected by erectile
dysfunction and mild hyperprolactinemia: a prospective, openlabel,
pilot study. Urology 2003;62(5):922-927.
Casella R, Deckart A, Bachmann A et al. The patient's selfevaluation
better predicts the degree of erectile dysfunction than
the response to intracavernous alprostadil testing. Urol Int
2004;72(3):216-220.
Chaiban J T, Azar S T. Erectile dysfunction in diabetic patients.
J Med Liban 2004;52(4):217-219.
Chatterjee R, Kottaridis P D, McGarrigle H H et al.
Management of erectile dysfunction by combination therapy
with testosterone and sildenafil in recipients of high-dose
therapy for haematological malignancies. Bone Marrow
Transplant 2002;29(7):607-610.
Cheitlin M D, Hutter A M, Brindis R G et al. Use of sildenafil
(Viagra) in patients with cardiovascular disease. Circulation
1999;99(1):168-177.
Chen J K, Hwang T I, Yang C R. Comparison of effects
following the intracorporeal injection of papaverine and
prostaglandin E1. Br J Urol 1992;69(4):404-407.
Chen J, Godschalk M F, Katz P G et al. Incidence of penile pain
after injection of a new formulation of prostaglandin E1.[see
comment]. Br J Urol 1995;154(1):77-79.
Chen J, Godschalk M F, Katz P G et al. Combining
intracavernous injection and external vacuum as treatment for
erectile dysfunction.[see comment]. Br J Urol
1995;153(5):1476-1477.
Chen J, Godschalk M, Katz P G et al. The lowest effective dose
of prostaglandin E1 as treatment for erectile dysfunction.. Br J
Urol 1995;153(1):80-81.
Chen J, Mabjeesh N J, Greenstein A et al. Clinical efficacy of
sildenafil in patients on chronic dialysis. Br J Urol
2001;165(3):819-821.
Chen J, Sofer M, Kaver I et al. Concomitant use of sildenafil
and a vacuum entrapment device for the treatment of erectile
dysfunction. Br J Urol 2004;171(1):292-295.
Chen K-K, Jiann B-P, Lin J S N et al. Erratum:
Efficacy and safety of on- demand oral tadalafil in the
treatment of men eith erectile dysfunction in Taiwan:
A randomized, double- blind, parallel, placeboconrolled
clinical study (Journal of Sexual Medicine
vol. 1 (2)). Br J Sex Med 2005;2(1):158
Cheng E. Real-life safety and efficacy of vardenafil in
the treatment of erectile dysfunction-results from
30,010 U.S. patients. Br J Sex Med 2007;4(2):432­
439.
Chew K K. Prevalence of hypogonadism in the aging
male and male erectile dysfunction in Asia-Pacific
countries. Asian J Androl 2003;5(2):171-172.
Chew K K, Stuckey B G A. Use of transurethral
alprostadil (MUSE) (prostaglandin E1) for glans
tumescence in a patient with penile prosthesis. Int J
Impot Res 2000;12(3):195-196.
Chew K K, Stuckey B G A, Thompson P L. Erectile
dysfunction, sildenafil and cardiovascular risk. Med J
Aust 2000;172(6):279-283.
Chia S. Management of premature ejaculation -- a
comparison of treatment outcome in patients with and
without erectile dysfunction. Int J Androl
2002;25(5):301-305.
Chia S J, Ramesh K, Earnest A. Clinical application of
prognostic factors for patients with organic causes of
erectile dysfunction on 100 mg of sildenafil citrate. Int
J Urol 2004;11(12):1104-1109.
Chiang H S, Wen T C, Liang J F. Titration study of
MUSE (Medicated Urethral System for Erection) in
erectile dysfunction. J Formos Med Assoc
2000;99(12):926-930.
Chiang H-S, Kao Y H, Sheu M T. Papaverine and
prostaglandin E1 gel applications for impotence. Ann
Acad Med Singapore 1995;24(5):767-769.
Chiang P-H, Tsai E-M, Chiang C-P. The role of
trazodone in the treatment of erectile dysfunction.
Kao-Hsiung i Hsueh Ko Hsueh Tsa Chih [Kaohsiung
Journal of Medical Sciences] 1994;10(6):287-294.
Chinegwundoh F, Anie K A. Treatments for priapism
in boys and men with sickle cell disease. [Review] [16
refs]. Cochrane Database Syst Rev
2004;(4):CD004198
Choi H K, Adimoelja A, Kim S C et al. A doseresponse
study of alprostadil sterile powder (S.Po.)
(Caverject) for the treatment of erectile dysfunction in
Korean and Indonesian men. Int J Impot Res
1997;9(1):47-51.
D-164